Infraspace is a new cloud-based platform for early-stage infrastructure planning and design. Save time. Lower costs. Reduce environmental impact. We focus on the early stage planning and design of the projects. That's when changes have the biggest impact on costs, quality, and sustainability. Infraspace is a new platform to empower teams to make better decisions based on data and analyses. ✅Optimization algorithms ✅Cost and CO2 estimates ✅Environmental analyses

PUBLICAE offers Tokenization of Political Attention by Empowering Citizens with Social & Economic Equity. Emancipation and enlightenment of the electorate increases voter turn-out and strengthens ethical-normative democratic principles. PUBLICAE ́s blockchain-based Ad-tech reward system is a public discourse, a dialectic exchange of conceptualised values which enables outreach efforts and organisational advertising strategies with rewarded audience targeting. Users can earn $STATE for their awareness as a token of appreciation by watching video ads from verified publishers like political parties, NGOs, educational institutions and faith based communities.

In this industry, we are not required to disclose the content of the products we sell. There are no requirements for the production, process, or raw material before the products are sold. The vagina is the most absorbent organ you have. If the products you use contain potentially toxic chemicals, you may run the risk of getting them right into your bloodstream. With this in mind as well as an idea for more transparent and to-the-point marketing, the founder of Flove, Jeanett wanted to develop a well-documented menstrual cup, of high quality and without toxic chemicals. After 2,5 years of testing, prototyping, failing, and researching Flove menstrual cup finally launched in May 2019. The cups are designed and developed in Norway and are produced in a certified "clean room" in Taiwan. Jeanette visited the factory in March 2019. The silicone used is certified medical-grade silicone from Dow Corning. The bag coming with the menstrual cup when buying one is made of lyocell Tencel, printed and sewn at Fabrikk Oslo. The packaging is made of carton and is printed at 07 media in Oslo. The goal is to make menstrual cup mainstream and to sell more sustainable products. *  One of the reasons Flove was established was to help girls to stay in school around the world. There are so many girls who can't afford sanitary pads and the result is often that many girls drop out of school. We are looking for the right partner to help us help as many girls as possible to stay in school.

Overhengende is er et samfunnsproblem som for mange bringer med seg bekymring og kostnader. Istapper har et stort skadepotensial og er til fare for mennesker og dyr. Etter flere år med produktutvikling og testing har vi kommet frem til et effektivt og enkelt produkt som forebygger nettopp dette.  Vi skreddersyr løsninger for de fleste tak og takrenner. Våre kunder består av bygårder, borettslag, barnehager, skoler, kjøpesenter og private hjem. Vi utfører befaring og komplett installasjon av ICECON varmebrett.

Grasp Your Future Our goal is to increase effectiveness and efficiency of medical treatments through person-centered care and improved clinician-patient communication. Grasp concept One-minute video presenting how Grasp works. Grasp Tracker A patented, CE-marked, and approved medical device. You simply squeeze the device when tracking your symptoms, behavior, and events. Grasp User app Through the user app, the doctor is connected to the patient´s everyday life in real-time: at home, at work, or while engaging in activities. Grasp Clinical solution The doctor can remotely and easily adjust the treatment, modify medical plans or give tailored behavioral feedback to increase the function of the patient

We have created a powerful tool for marketing and promoting real estate. Promo will help to streamline the purchase-/sales process. Our package is providing the buyer / tenant a total view of the property, its possibilities in terms of spacing, room connections, landscapes etc. We are using professional real estate agents who create a voice-over so that our video will be as close to a physical listing as possible. The viewer can watch our content anywhere or anytime! We are aiming for both commercial property, private property, sales and rent.

WAKT er et oppstartsselskap basert i Drammen. Våre kompetanseområder ligger innenfor: Robotic Process Automation Development,Data EngineeringMachine LearningQuantitative financial Engineering and Analysis.Application Development Vi streber etter å ta i bruk moderne teknologi for å levere resultatene vi eller våre kunder er ute etter.

OptoScale supplies fish farmers with precise and relevant data empowering them to make decision that improve productivity, sustainability, and animal welfare. Our data informs fish farmers about how their production is going, by accurately measuring the size of fish, growth, welfare status, and parasite counting. Our head office is in Trondheim, Norway, and we deliver to our great customers around the world. We are continuously interested in hiring great people across most of our functions: HW development, AI/ML, electronics, sales and customer success.

We design and build aerial drones that revolutionize how people wash and paint large structures. Today liquid application on buildings is done by manual labor in risky environments using scaffolding and lifts. We are designing and building aerial drones that can spray liquids on buildings safely and highly efficiently.

The problem:The easiest pollution to clean up, is what's on the surface. Lost fishing gear is hidden on the bottom. It doesn't only cause pollution, but also torture and death of enormous amounts of animals. About 10% of the total amount of seafood harvested are wasted to ghost fishing. Hundreds of thousands of crab- and lobster traps are lost every years. In the Florida Keys alone an estimated 100 000 traps are lost every yearCaptured animals starve to death, and become bait for others to follow. Lost traps thus become endless killing machines at a severe societal and environmental cost. Over time traps also start dissolving, releasing microplastics into the ocean, working its way into the food chain and polluting our seafood. The solution:ResqUnit is a device that's mounted on top of a trap or a pot. If the trap is left under water for a longer period of time, ResqUnit activates and floats to the surface. Thus enabling you to retrieve it.We are hoping to raise awareness so that anyone who sees the unique floating device, will either pull up the equipment or report it's location. That way everybody can do their part keeping the oceans cleaner and stop the unnecessary killing of sea life.

Monio AS (org. nr. 913 978 617) er et heleid datterselskap av SpareBank 1 SR-Bank ASA (org. nr. 937 895 321). Monio AS formidler lån til små og mellomstore bedrifter og er regulert av Finanstilsynet med tillatelse til å drive virksomhet som betalingsforetak og er registrert som låneformidler. Som lånformidler er Monio ikke en part i låneavtalen mellom långiver og låntaker.

Moderne Media ble startet med et ønske om å formidle gode historier. Det er fortsatt kjerneverdien i alt vi gjør. Med podkast, TV, film, reklame og sosiale medier, har vi flere muligheter enn noen gang til å produsere og dele gode historier.Folkene du møter i Moderne Media jobber med det de synes er morsomst, og det de er flinkest til. Vi har oppdaget at de to tingene har en sammenheng. Derfor prøver vi å rendyrke personligheter og individer.

Otivio’s main product, FlowOx™, is addressing chronic wounds with focus on peripheral arterial disease (PAD), which is a serious condition leading to pain, chronic wounds and in many cases amputation and mortality. The patient population is very large and increasing. There are limited adequate treatment options offered to the patients aside from surgical interventions. FlowOx™ is a non-invasive product intended for home use. Long-term patient testing in more than 50 patients documents increased blood flow, reduced pain and wound healing. FlowOx™ is CE marked. In fourth quarter 2017 had its commercial break-through through sales of FlowOx to public customers.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

An employee management system that´s designed to be easy to use. By thinking differently and smarter than our competitors we are making an employee management system that is easy to use, especially for elderly users. And the system is not complicated. We are focusing on that our typical customer is both 20 and 60 years old. Therefore is it important for us to listen to them, so we can make a system that is understandable for them. By getting satisfied customers, we will be the preferred system for small and medium-sized businesses. We are providing a web-based system that is available on all devices. In our system, you find timesheets, deviation, weekly plans/schedules, resource-planner, groups, CRM, newsfeeds, to-do-list, use on projects, travel logs, and many more tools for communication and registration. We want to make a smart and effective day for small and medium businesses. KPI - Key Performance Indicator:- MVP - Minimum Viable Product- 20 costumers- Founding from Innovation Norway (marked clarification)- 2016 revenue: 318.000NOK